Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a major global health challenge, necessitating the development of innovative therapeutic strategies. The aim of this study was to explore the potential of novel drug delivery systems for targeted cancer therapy. The research focused on designing and evaluating drug delivery systems that can enhance the specificity and efficacy of anticancer drugs while minimizing off-target effects. Various nanotechnology-based approaches were investigated, including liposomes, nanoparticles, and micelles, for their ability to deliver therapeutic agents selectively to cancer cells. The introduction section provides a comprehensive overview of the background of the study, highlighting the current challenges in cancer treatment and the need for targeted drug delivery systems. The problem statement emphasizes the limitations of conventional cancer therapy and the potential advantages of novel drug delivery approaches. The objectives of the study are outlined, aiming to design and optimize drug delivery systems for improved cancer treatment outcomes. The scope of the study is defined, focusing on the development and evaluation of novel drug delivery systems for targeted cancer therapy. The literature review chapter critically evaluates existing research on drug delivery systems for cancer therapy, highlighting the strengths and limitations of various approaches. Key concepts such as nanomedicine, drug targeting, and cancer cell biology are discussed to provide a theoretical framework for the study. The research methodology chapter outlines the experimental design and methods used in the study, including the synthesis and characterization of drug delivery systems, in vitro and in vivo evaluation of drug release and anticancer efficacy, and data analysis techniques. The discussion of findings chapter presents the results of the study, including the design and optimization of drug delivery systems, their physicochemical properties, drug release profiles, and anticancer activity. The implications of the findings are discussed in the context of advancing targeted cancer therapy. In conclusion, the study demonstrates the potential of novel drug delivery systems for targeted cancer therapy, offering improved selectivity and efficacy compared to conventional treatment approaches. The significance of the study lies in its contribution to the field of nanomedicine and cancer research, providing insights into the design and optimization of drug delivery systems for clinical translation. Future research directions are suggested to further enhance the development of targeted drug delivery systems for personalized cancer therapy.